Hailey-Hailey Disease is Associated with Diabetes: A Population-based Cohort Study, Clinical Cohort Study, and Pedigree Analysis.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
28 Nov 2023
Historique:
received: 08 03 2023
accepted: 27 09 2023
medline: 29 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Hailey-Hailey disease is a rare hereditary skin disease caused by mutations in the ATP2C1 gene encoding the secretory pathway Ca2+/Mn2+-ATPase 1 (SPCA1) protein. Extracutaneous manifestations of Hailey-Hailey disease are plausible but still largely unknown. The aim of this study was to explore the association between Hailey-Hailey disease and diabetes. A population-based cohort study of 347 individuals with Hailey-Hailey  disease was performed to assess the risks of type 1  diabetes and type 2 diabetes, using Swedish nationwide registries. Pedigrees from 2 Swedish families with Hailey-Hailey disease were also investigated: 1 with concurrent type 1 diabetes and HLA-DQ3, the other with type 2 diabetes. Lastly, a clinical cohort with 23 individuals with Hailey-Hailey disease and matched healthy controls was evaluated regarding diabetes. In the register data males with Hailey-Hailey disease had a 70% elevated risk of type 2 diabetes, whereas no  excess risk among women could be confirmed. In both pedigrees an unusually high inheritance for diabetes was observed. In the clinical cohort, individuals with Hailey-Hailey disease displayed a metabolic phenotype indicative of type 2 diabetes. Hailey-Hailey disease seems to act as a synergistic risk factor for diabetes. This study indicates, for the first time, an association between Hailey-Hailey disease and diabetes and represents human evidence that SPCA1 and the Golgi apparatus may be implicated in diabetes pathophysiology.

Identifiants

pubmed: 38014829
doi: 10.2340/actadv.v103.10436
pmc: PMC10695124
doi:

Substances chimiques

Calcium-Transporting ATPases EC 7.2.2.10
ATP2C1 protein, human EC 7.2.2.10

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv10436

Références

Ann Dermatol. 2018 Jun;30(3):265-275
pubmed: 29853739
Diabet Med. 2020 Oct;37(10):1723-1727
pubmed: 31390484
J Am Acad Dermatol. 2019 Dec;81(6):1425-1426
pubmed: 31163229
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38
pubmed: 34964875
Lancet. 2018 Jun 16;391(10138):2449-2462
pubmed: 29916386
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14074-9
pubmed: 16966600
Genes (Basel). 2015 Mar 12;6(1):87-123
pubmed: 25774817
Am J Med. 2003 Apr 15;114(6):438-44
pubmed: 12727576
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1204-13
pubmed: 15336968
Biofactors. 2011 May-Jun;37(3):150-8
pubmed: 21674634
Curr Opin Immunol. 2016 Dec;43:60-66
pubmed: 27718448
Pediatr Diabetes. 2020 Mar;21(2):259-265
pubmed: 31702838
J Biol Chem. 2005 Mar 11;280(10):9467-73
pubmed: 15623514
Am J Clin Dermatol. 2020 Feb;21(1):49-68
pubmed: 31595434
Mol Genet Genomic Med. 2021 Feb;9(2):e1580
pubmed: 33345454
Curr Diab Rep. 2011 Dec;11(6):533-42
pubmed: 21912932
Nat Rev Nephrol. 2023 Mar;19(3):168-184
pubmed: 36316388
Eur J Epidemiol. 2017 Sep;32(9):765-773
pubmed: 28983736
J Appl Genet. 2020 May;61(2):187-193
pubmed: 31983024
Endocrinology. 2020 Feb 1;161(2):
pubmed: 31796960
Diabetes. 2020 Nov;69(11):2364-2376
pubmed: 32820009
Mol Aspects Med. 2015 Apr;42:105-18
pubmed: 25579745
Cell Calcium. 2006 Nov-Dec;40(5-6):539-51
pubmed: 17030367
J Clin Endocrinol Metab. 2007 Jun;92(6):2017-29
pubmed: 17389701
Diabetes Care. 2021 Nov;44(11):2449-2456
pubmed: 34670785
J Biol Chem. 2007 Sep 7;282(36):26517-27
pubmed: 17597066
Diabetes. 2018 Nov;67(11):2389-2396
pubmed: 30131390
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R67-74
pubmed: 16651371
Diabetol Metab Syndr. 2020 Feb 05;12:12
pubmed: 32042314
Diabetes. 1987 Jan;36(1):93-9
pubmed: 3792666
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213

Auteurs

Philip Curman (P)

Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. philip.curman@ki.se.

William Jebril (W)

Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden.

Carmella Evans-Molina (C)

Departments of Anatomy, Cell Biology, and Physiology; Biochemistry and Molecular Biology; Medicine; Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202; The Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN 46202; Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; Roudebush VA Medical Center, Indianapolis, IN 46202, USA.

Etty Bachar-Wikstrom (E)

Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Henrik Larsson (H)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Martin Cederlöf (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Jakob D Wikström (JD)

Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH